| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76195fd1cd08192222699d8e7a88c231 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-568 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-568 |
| filingDate |
1982-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1984-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f6cf8e9282812c3f4ebcb006fd5e2f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_770752c2bb02d8ba76e3908dcef729f2 |
| publicationDate |
1984-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4478749-A |
| titleOfInvention |
2-Oxo-1-(substituted phosphorous)azetidines |
| abstract |
Antibacterial activity is exhibited by β-lactams having a phosphinic or phosphonic substituent in the 1-position and an acylamino substituent in the 3-position. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4837318-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4883869-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9403863-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-597632-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4937330-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0218323-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5502200-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4584132-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4723002-A |
| priorityDate |
1981-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |